P20GM155890
Project Grant
Overview
Grant Description
Translational Science Engaging North Dakota (TRANSCEND) - TRANSCEND-Overall Overall Summary
Our objective is a clinical and translational research development program (CTR-D) that expands clinical and translational (C&T) research focused on health problems in North Dakota (ND). The name of our CTR-D, TRANSCEND, is an acronym for Translational Science Engaging North Dakota. TRANSCEND focuses on diseases prevalent in ND and their potential environmental exposures.
The high prevalence of several health conditions in ND, e.g., colorectal cancer and neurodegenerative diseases like Alzheimer’s and Parkinson’s diseases, as well as psychiatric problems such as high youth suicide rates, makes it ideal for investment in research infrastructure, as advances for problems prevalent in ND can be applied to those problems occurring elsewhere. Partner institutions in TRANSCEND are the University of North Dakota (UND,) North Dakota State University (NDSU), and Sanford Health.
The specific aims of TRANSCEND are to: Aim 1: Elevate the profile of C&T research throughout North Dakota universities and clinics. Aim 2. Streamline the “road” to successful C&T research by removing roadblocks and by offering “roadside” assistance (practical research training and assistance) to investigators. Aim 3. Make tangible, positive impacts on the health of North Dakotans.
We have identified significant challenges to the conduct of C&T research, including faculty with limited C&T training, difficult patient access (UNDSMHS does not own a hospital), and challenges for faculty in forming collaborations. We have developed several strategies to overcome these challenges, including support for department chairs and faculty to enroll in C&T training courses from Mayo Clinic, Harvard, and Stanford University. We have established collaborations with Sanford and community clinics, e.g., the Community Health Association of the Dakotas (CHAD), to improve access to patient and patient data.
We have developed several collaboration methods, including the TRANSCEND portal with the names, research interests, and contact information of basic and clinical scientists interested in C&T research, and a personal research navigator who can function as a matchmaker to establish teams of researchers. TRANSCEND will accomplish its aims with 4 scientific cores: Professional Development; Health Research (Pilot Studies); Community Engagement; and Research Design. A central administrative core supports the cores.
Each of the cores is directed by experienced, extramurally-funded faculty with expertise in investigator training and mentorship. TRANSCEND innovates in many ways, including a re-entry pilot in which previously unfunded investigators “re-enter” the grant process, inclusion of engineering faculty, and financial incentives for submitting extramural grants. Our community engagement and outreach core is highly experienced in working with indigenous/minority communities.
Another innovation is our Community Physician at Large (COPAL) who aligns TRANSCEND with community priorities. With its epidemiologic/public health orientation, TRANSCEND embraces a “trench to bench” and “bench to trench” approach that broadens the typical “bench to bedside” model. Our vision is that TRANSCEND will transform the academic culture in ND, train future C&T leaders, and contribute to our long-term goal of improving health in ND.
Our objective is a clinical and translational research development program (CTR-D) that expands clinical and translational (C&T) research focused on health problems in North Dakota (ND). The name of our CTR-D, TRANSCEND, is an acronym for Translational Science Engaging North Dakota. TRANSCEND focuses on diseases prevalent in ND and their potential environmental exposures.
The high prevalence of several health conditions in ND, e.g., colorectal cancer and neurodegenerative diseases like Alzheimer’s and Parkinson’s diseases, as well as psychiatric problems such as high youth suicide rates, makes it ideal for investment in research infrastructure, as advances for problems prevalent in ND can be applied to those problems occurring elsewhere. Partner institutions in TRANSCEND are the University of North Dakota (UND,) North Dakota State University (NDSU), and Sanford Health.
The specific aims of TRANSCEND are to: Aim 1: Elevate the profile of C&T research throughout North Dakota universities and clinics. Aim 2. Streamline the “road” to successful C&T research by removing roadblocks and by offering “roadside” assistance (practical research training and assistance) to investigators. Aim 3. Make tangible, positive impacts on the health of North Dakotans.
We have identified significant challenges to the conduct of C&T research, including faculty with limited C&T training, difficult patient access (UNDSMHS does not own a hospital), and challenges for faculty in forming collaborations. We have developed several strategies to overcome these challenges, including support for department chairs and faculty to enroll in C&T training courses from Mayo Clinic, Harvard, and Stanford University. We have established collaborations with Sanford and community clinics, e.g., the Community Health Association of the Dakotas (CHAD), to improve access to patient and patient data.
We have developed several collaboration methods, including the TRANSCEND portal with the names, research interests, and contact information of basic and clinical scientists interested in C&T research, and a personal research navigator who can function as a matchmaker to establish teams of researchers. TRANSCEND will accomplish its aims with 4 scientific cores: Professional Development; Health Research (Pilot Studies); Community Engagement; and Research Design. A central administrative core supports the cores.
Each of the cores is directed by experienced, extramurally-funded faculty with expertise in investigator training and mentorship. TRANSCEND innovates in many ways, including a re-entry pilot in which previously unfunded investigators “re-enter” the grant process, inclusion of engineering faculty, and financial incentives for submitting extramural grants. Our community engagement and outreach core is highly experienced in working with indigenous/minority communities.
Another innovation is our Community Physician at Large (COPAL) who aligns TRANSCEND with community priorities. With its epidemiologic/public health orientation, TRANSCEND embraces a “trench to bench” and “bench to trench” approach that broadens the typical “bench to bedside” model. Our vision is that TRANSCEND will transform the academic culture in ND, train future C&T leaders, and contribute to our long-term goal of improving health in ND.
Awardee
Funding Goals
THE NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES (NIGMS) SUPPORTS BASIC RESEARCH THAT INCREASES OUR UNDERSTANDING OF BIOLOGICAL PROCESSES AND LAYS THE FOUNDATION FOR ADVANCES IN DISEASE DIAGNOSIS, TREATMENT, AND PREVENTION. NIGMS ALSO SUPPORTS RESEARCH IN SPECIFIC CLINICAL AREAS THAT AFFECT MULTIPLE ORGAN SYSTEMS: ANESTHESIOLOGY AND PERI-OPERATIVE PAIN, CLINICAL PHARMACOLOGY ?COMMON TO MULTIPLE DRUGS AND TREATMENTS, AND INJURY, CRITICAL ILLNESS, SEPSIS, AND WOUND HEALING.? NIGMS-FUNDED SCIENTISTS INVESTIGATE HOW LIVING SYSTEMS WORK AT A RANGE OF LEVELSFROM MOLECULES AND CELLS TO TISSUES AND ORGANSIN RESEARCH ORGANISMS, HUMANS, AND POPULATIONS. ADDITIONALLY, TO ENSURE THE VITALITY AND CONTINUED PRODUCTIVITY OF THE RESEARCH ENTERPRISE, NIGMS PROVIDES LEADERSHIP IN SUPPORTING THE TRAINING OF THE NEXT GENERATION OF SCIENTISTS, ENHANCING THE DIVERSITY OF THE SCIENTIFIC WORKFORCE, AND DEVELOPING RESEARCH CAPACITY THROUGHOUT THE COUNTRY.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Grand Forks,
North Dakota
582027306
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 98% from $2,187,647 to $4,334,294.
University Of North Dakota was awarded
TRANSCEND: Elevating Clinical Translational Research North Dakota Health
Project Grant P20GM155890
worth $4,334,294
from the National Institute of General Medical Sciences in July 2024 with work to be completed primarily in Grand Forks North Dakota United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.859 Biomedical Research and Research Training.
The Project Grant was awarded through grant opportunity IDeA Clinical and Translational Research Development (CTR-D) Award (P20-Clinical Trial Optional).
Status
(Ongoing)
Last Modified 8/20/25
Period of Performance
7/1/24
Start Date
6/30/29
End Date
Funding Split
$4.3M
Federal Obligation
$0.0
Non-Federal Obligation
$4.3M
Total Obligated
Activity Timeline
Transaction History
Modifications to P20GM155890
Additional Detail
Award ID FAIN
P20GM155890
SAI Number
P20GM155890-4050105026
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NS00 NIH National Institute of General Medical Sciences
Funding Office
75NS00 NIH National Institute of General Medical Sciences
Awardee UEI
RSWNKK6J8CF3
Awardee CAGE
4B858
Performance District
ND-00
Senators
John Hoeven
Kevin Cramer
Kevin Cramer
Modified: 8/20/25